Hyaluronic acid-fabricated nanogold delivery of the inhibitor of apoptosis protein- 2 siRNAs inhibits benzo[a]pyrene-induced oncogenic properties of lung cancer A549 cells

Nanotechnology

Volumn 26, Issue 10, 2015, Pages

  Lin, Chung Ming ^a   Kao, Wei Chien ^b   Yeh, Chun An ^b   Chen, Hui Jye ^b   Lin, Shinn Zong ^b,c,d   Hsieh, Hsien Hsu ^e   Sun, Wei Shen ^b   Chang, Chih Hsuan ^b   Hung, Huey Shan ^b,c  

^a MING CHUAN UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY BEIGANG HOSPITAL   (Taiwan)

^e TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Benzo a pyrene (BaP); Hyaluronic acid gold nanoparticle (AuNP HA); Inhibitor of apoptosis protein 2 (IAP 2) sirna

Indexed keywords

BIOCOMPATIBILITY; BIOLOGICAL ORGANS; CELL DEATH; CELL PROLIFERATION; CELLS; CYTOLOGY; DISEASES; ENZYME ACTIVITY; ENZYME INHIBITION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; FUMES; GENE EXPRESSION; GENE THERAPY; GOLD; METAL NANOPARTICLES; MOLECULAR BIOLOGY; NANOPARTICLES; OILS AND FATS; ORGANIC ACIDS; PROTEINS; PYRENE; RNA; SPECTROMETERS;

BENZO[A]PYRENE; FLUORESCEIN ISOTHIOCYANATE; FOURIER TRANSFORM INFRARED SPECTROMETER; FUNCTIONALIZED GOLD NANOPARTICLES; GOLD NANOPARTICLES; INHIBITOR OF APOPTOSIS PROTEINS; MATRIX METALLOPROTEINASE-2; THERAPEUTIC APPLICATION;

HYALURONIC ACID;

BENZO[A]PYRENE; BIOMATERIAL; CD44 PROTEIN, HUMAN; GOLD; HERMES ANTIGEN; HYALURONIC ACID; INHIBITOR OF APOPTOSIS PROTEIN; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA;

CELL SURVIVAL; CHEMICALLY INDUCED; CHEMISTRY; DEVICES; DRUG DELIVERY SYSTEM; DRUG EFFECTS; HUMAN; LUNG NEOPLASMS; TUMOR CELL LINE;

ANTIGENS, CD44; BENZO(A)PYRENE; BIOCOMPATIBLE MATERIALS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; GOLD; HUMANS; HYALURONIC ACID; INHIBITOR OF APOPTOSIS PROTEINS; LUNG NEOPLASMS; NANOPARTICLES; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING;

EID: 84923666969     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/26/10/105101     Document Type: Article

References (62)

1. Fire A, Xu S, Montgomery M K, Kostas S A, Driver S E and Mello C C 1998 Nature 391 806-11
2. Wall N R and Shi Y 2003 Lancet 362 1401-3
3. Lee S H, Mok H, Jo S, Hong C A and Park T G 2011 Biomaterials 32 2359-68
4. Li X, Xie Q R, Zhang J, Xia W and Gu H 2011 Biomaterials 32 9546-56
5. Shrestha R, Elsabahy M, Florez-Malaver S, Samarajeewa S and Wooley K L 2012 Biomaterials 33 8557-68
6. Gil P R and Parak W J 2008 ACS Nano 2 2200-5
7. Peer D, Karp J M, Hong S, Farokhzad O C, Margalit R and Langer R 2007 Nat. Nanotechnology 2 751-60
8. Lammers T, Aime S, Hennink W E, Storm G and Kiessling F 2011 Acc. Chem. Res. 44 1029-38
9. Ghosh P, Han G, De M, Kim C K and Rotello V M 2008 Adv. Drug Deliv. Rev. 60 1307-15
10. Conde J, Doria G and Baptista P 2012 J. Drug Deliv. 2012 751075
11. Nativo P, Prior I A and Brust M 2008 ACS Nano 2 1639-44
12. Levy R, Shaheen U, Cesbron Y and See V 2010 Nano Rev. 1 4889
13. Cho E C, Xie J, Wurm P A and Xia Y 2009 Nano Lett. 9 1080-4
14. Lund T, Callaghan M F, Williams P, Turmaine M, Bachmann C, Rademacher T, Roitt I M and Bayford R 2011 Biomaterials 32 9776-84
15. Kumari A and Yadav S K 2011 Expert Opin. Drug Deliv. 8 141-51
16. Chithrani D B 2010 Mol. Membr. Biol. 27 299-311
17. Verma A, Uzun O, Hu Y, Hu Y, Han H S, Watson N, Chen S, Irvine D J and Stellacci F 2008 Nat. Mater. 7 588-95
18. Lee S K, Han M S, Asokan S and Tung C H 2011 Small 7 364-70
19. Kim S T, Chompoosor A, Yeh Y C, Agasti S S, Solfiell D J and Rotello V M 2012 Small 8 3253-6
20. Giljohann D A, Seferos D S, Prigodich A E, Patel P C and Mirkin C A 2009 J. Am. Chem. Soc. 131 2072-3
21. Lee Y, Lee S H, Kim J S, Maruyama A, Chen X and Park T G 2011 J. Control. Release: Official J. Control. Release Soc. 155 3-10
22. Song W J, Du J Z, Sun T M, Zhang P Z and Wang J 2010 Small 6 239-46
23. Lee J S, Green J J, Love K T, Sunshine J, Langer R and Anderson D G 2009 Nano Lett. 9 2402-6
24. Lee S H, Bae K H, Kim S H, Lee K R and Park T G 2008 Int. J. Pharmaceutics 364 94-101
25. Guo S et al 2010 ACS Nano 4 5505-11
26. Choi K Y, Chung H, Min K H, Yoon H Y, Kim K, Park J H, Kwon I C and Jeong S Y 2010 Biomaterials 31 106-14
27. Lee H, Ahn C H and Park T G 2009 Macromol. Biosci. 9 336-42
28. Mayol L, Biondi M, Russo L, Malle B M, Schwach-Abdellaoui K and Borzacchiello A 2014 Carbohydrate Polym. 102 110-6
29. Saravanakumar G, Choi K Y, Yoon H Y, Kim K, Park J H, Kwon I C and Park K 2010 Int. J. Pharmaceutics 394 154-61
30. Cho H J, Yoon H Y, Koo H, Ko S H, Shim J S, Lee J H, Kim K, Kwon I C and Kim D D 2011 Biomaterials 32 7181-90
31. Orian-Rousseau V 2010 Eur. J. Cancer 46 1271-7
32. Peer D and Margalit R 2004 Int. J. Cancer. J. Int. Cancer 108 780-9
33. Ruhela D, Kivimae S and Szoka F C 2014 Bioconjugate Chem. 25 718-23
34. Peer D and Margalit R 2004 Neoplasia 6 343-53
35. Hung H S, Chou C W, Sun W S, Lin S Z, Hsuch K W, Chu M Y and Hsu S 2012 J. Neurosci. Neuroeng. 1 143-52
36. Gao Y T, Blot WJ, Zheng W, Fraumeni J F and Hsu C W1988 Int. J. Epidemiol. 17 277-80
37. Zhong L, Goldberg M S, Parent M E and Hanley J A 1999 Scand. J. Work Environ. Health 25 309-16
38. Yang S C, Jenq S N, Kang Z C and Lee H 2000 Chem. Res. Toxicol. 13 1046-50
39. Lin J M and Liou S J 2000 Bull. Environ. Contamination Toxicol. 64 817-24
40. Fullana A, Carbonell-Barrachina A A and Sidhu S 2004 J. Agric. Food Chem. 52 5207-14
41. Lin S Y, Tsai S J, Wang L H, Wu M F and Lee H 2002 Nutrition Cancer 44 95-101
42. Hung H S, Wu W J, Cheng Y W, Wu T C, Chang K L and Lee H 2007 Mutation Res. 628 107-16
43. Hung H S, Wu W J, Cheng Y W, Wu M F, Chang K L and Lee H 2005 J. Toxicol. Environ. Health. A 68 1525-35
44. Rothe M, Pan M G, Henzel W J, Ayres T M and Goeddel D V 1995 Cell 83 1243-52
45. Deveraux Q L, Takahashi R, Salvesen G S and Reed J C 1997 Nature 388 300-4
46. Deveraux Q L, Leo E, Stennicke H R, Welsh K, Salvesen G S and Reed J C 1999 EMBO J. 18 5242-51
47. Schimmer A D 2004 Cancer Res. 64 7183-90
48. LeBlanc A C 2003 Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27 215-29
49. Dubrez L, Berthelet J and Glorian V 2013 Onco. Targets Ther. 9 1285-304
50. Li F, Ackermann E J, Bennett C F, Rothermel A L, Plescia J, Tognin S, Villa A, Marchisio P C and Altieri D C 1999 Nat. Cell Biol. 1 461-6
51. Ding D C, Shyu W C, Chiang M F, Lin S Z, Chang Y C, Wang H J, Su C Y and Li H 2007 Neurobiol. Dis. 27 339-53
52. Hung H S, Chu M Y, Lin C H, Wu C C and Hsu S H 2012 J. Biomed. Mater. Res. A 100 26-37
53. Hung H S, Tang C M, Lin C H, Lin S Z, Chu M Y, Sun W S, Kao W C, Hsieh H H, Huang C Y and Hsu S H 2013 PLoS One 8 e65738
54. Hadler-Olsen E, Winberg J O and Uhlin-Hansen L 2013 Tumour Biol.: J. Int. Soc. Oncodevelopmental Biol. Med. 34 2041-51
55. Ko Y C, Cheng L S, Lee C H, Huang J J, Huang M S, Kao E L, Wang H Z and Lin H J 2000 Am. J. Epidemiol. 151 140-7
56. Gyrd-Hansen M and Meier P 2010 Nat. Rev. Cancer 10 561-74
57. Reischl D and Zimmer A 2009 Nanomedicine 5 8-20
58. Kesharwani P, Gajbhiye V and Jain N K 2012 Biomaterials 33 7138-50
59. Jain K K 2005 Drug Discovery Today 10 1435-42
60. Gao H, Shi W and Freund L B 2005 Proc. Natl. Acad. Sci. USA 102 9469-74
61. Kim S H, Jeong J H, Lee S H, Kim S W and Park T G 2006 J. Control. Release: Of ficial J. Control. Release Soc. 116 123-9
62. Li W and Szoka F C Jr 2007 Pharmaceutical Res. 24 438-49